Myeloid Tumor
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Myeloid Tumor (NCT05148442) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-12-28 |
| ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center (NCT03608059) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2018-07-28 |
Track Myeloid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.